Evidence map›Paper›PMID 27590115›Full record

ArticleImmunity2016

Hematopoietic Stem Cells Are the Major Source of Multilineage Hematopoiesis in Adult Animals.

Catherine M Sawai, Sonja Babovic, Samik Upadhaya, David J H F Knapp, Yonit Lavin, Colleen M Lau, Anton Goloborodko, Jue Feng, Joji Fujisaki, Lei Ding and 4 more

Open access · bronzeAbstract read
In one paragraph

Article in Immunity, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 235 papers.

0numbers the graph read from it
0cells of the map it votes in
235citing papers in PubMed
32.1field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

235 citing papers in PubMed, 371 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Review
  6. Review
  7. CCR5 marks a subset of mouse hematopoietic stem cells that are myeloid primed and expand with age.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  8. Article
  9. Real-ambient PMParticle and fibre toxicology · 2025
    Article
  10. Lineage tracing of both quiescent G0 and active Hoxb5+ LT-HSCs that actively contribute to homeostatic mouse hematopoiesis.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  11. Article
  12. Article
  13. Review
  14. Direct megakaryopoiesis.Current opinion in hematology · 2025
    Review
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article

175 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

14 authors at 5 institutions in 2 countries.

Catherine M SawaiDepartment of Pathology, New York University Langone Medical Center, New York, NY 10016, USA. Electronic address: catherine.sawai@nyumc.org.
Sonja BabovicTerry Fox Laboratory, British Columbia Cancer Agency and University of British Columbia, Vancouver, BC V5Z 4E6, Canada.
Samik UpadhayaDepartment of Pathology, New York University Langone Medical Center, New York, NY 10016, USA; Graduate Program in Pathobiology and Molecular Medicine, Columbia University Medical Center, New York, NY 10032, USA.
David J H F KnappTerry Fox Laboratory, British Columbia Cancer Agency and University of British Columbia, Vancouver, BC V5Z 4E6, Canada.
Yonit LavinDepartment of Oncological Science, The Tisch Cancer Institute and The Immunology Institute, Mount Sinai School of Medicine, New York, NY 10029, USA.
Colleen M LauDepartment of Pathology, New York University Langone Medical Center, New York, NY 10016, USA.
Anton GoloborodkoDepartment of Physics, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.
Jue FengDepartment of Pathology, New York University Langone Medical Center, New York, NY 10016, USA.
Joji FujisakiDepartment of Pediatrics and Columbia Center for Translational Immunology, Columbia University Medical Center, New York, NY 10032, USA.
Lei DingDepartment of Regenerative Medicine and Department of Microbiology and Immunology, Columbia University Medical Center, New York, NY 10032, USA.
Leonid A MirnyDepartment of Physics, Massachusetts Institute of Technology, Cambridge, MA 02139, USA; Institute for Medical Engineering and Science, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.
Miriam MeradDepartment of Oncological Science, The Tisch Cancer Institute and The Immunology Institute, Mount Sinai School of Medicine, New York, NY 10029, USA.
Connie J EavesTerry Fox Laboratory, British Columbia Cancer Agency and University of British Columbia, Vancouver, BC V5Z 4E6, Canada.
Boris ReizisDepartment of Pathology, New York University Langone Medical Center, New York, NY 10016, USA; Department of Medicine, New York University Langone Medical Center, New York, NY 10016, USA; Department of Microbiology and Immunology, Columbia University Medical Center, New York, NY 10032, USA. Electronic address: boris.reizis@nyumc.org.
Columbia University Irving Medical Center · USBC Cancer Agency · CANYU Langone Health · USIcahn School of Medicine at Mount Sinai · USMassachusetts Institute of Technology · US

Funding

Vaccine FacilityP30CA016087 · NCI · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI ADRIANA HEGUY · 1985 to 2026
$83.1M
TRAINING IN CELLULAR, MOLECULAR AND BIOPHYSICAL STUDIEST32GM008224 · NIGMS · COLUMBIA UNIV NEW YORK MORNINGSIDE · PI LIEM, RONALD K. · 1987 to 2021
$9.9M
ERK control of Dendritic Cell Differentiation, Homeostasis and DiseaseR01CA154947 · NCI · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI CARL E ALLEN, MIRIAM MERAD · 2011 to 2026
$7.0M
Molecular Control of Plasmacytoid Dendritic Cell Development and FunctionR37AI072571 · NIAID · UNIVERSITY OF CHICAGO · PI Boris Reizis · 2018 to 2026
$5.3M
Privileged and primitive hematopoietic stem cells, niches, and regulatory T cellsR01HL129506 · NHLBI · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI FUJISAKI, JOJI · 2016 to 2025
$5.1M
Training Program in Immunology and Inflammation.T32AI100853 · NIAID · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI Susan Ruth Schwab · 2012 to 2026
$4.5M
Molecular Control of Plasmacytoid Dendritic Cell Development and FunctionR01AI072571 · NIAID · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI REIZIS, BORIS · 2008 to 2017
$4.1M
Contribution of the cutaneous APC network to melanoma progression and therapy.R01CA173861 · NCI · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI MERAD, MIRIAM · 2013 to 2017
$2.1M
Regulation of hematopoietic stem cells and leukemia stem cells by thrombopoietinR01HL132074 · NHLBI · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI DING, LEI · 2016 to 2020
$2.0M
Harnessing Csf-2 compartmentalized role on tissue resident phagocytes to uncouple anti-tumoral from pathological immunity induced by checkpoint inhibitorsR01CA190400 · NCI · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI MERAD, MIRIAM · 2015 to 2019
$1.9M
Dissecting the aging of hematopoietic stem cells by genetic tracing in vivoR01AG049074 · NIA · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI REIZIS, BORIS · 2015 to 2019
$1.7M
Stem Cells and Cell Lineage SpecificationT32HD055165 · NICHD · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI HOBERT, OLIVER · 2007 to 2011
$1.3M
CIHRNCI NIH HHS P30 CA016087NCI NIH HHS R01 CA154947NCI NIH HHS R01 CA173861NCI NIH HHS R01 CA190400NHLBI NIH HHS R01 HL129506NHLBI NIH HHS R01 HL132074NHLBI NIH HHS R21 HL113678NIAID NIH HHS R01 AI072571NIAID NIH HHS R21 AI115382NIAID NIH HHS R37 AI072571NIAID NIH HHS T32 AI100853NIA NIH HHS R01 AG049074NICHD NIH HHS T32 HD055165NIGMS NIH HHS T32 GM008224
6 · The paper itself

Abstract

Hematopoietic stem cells (HSCs) sustain long-term reconstitution of hematopoiesis in transplantation recipients, yet their role in the endogenous steady-state hematopoiesis remains unclear. In particular, recent studies suggested that HSCs provide a relatively minor contribution to immune cell development in adults. We directed transgene expression in a fraction of HSCs that maintained reconstituting activity during serial transplantations. Inducible genetic labeling showed that transgene-expressing HSCs gave rise to other phenotypic HSCs, confirming their top position in the differentiation hierarchy. The labeled HSCs rapidly contributed to committed progenitors of all lineages and to mature myeloid cells and lymphocytes, but not to B-1a cells or tissue macrophages. Importantly, labeled HSCs gave rise to more than two-thirds of all myeloid cells and platelets in adult mice, and this contribution could be accelerated by an induced interferon response. Thus, classically defined HSCs maintain immune cell development in the steady state and during systemic cytokine responses.

Indexed as

AnimalsBlood PlateletsB-LymphocytesCell DifferentiationCell LineageHematopoiesisHematopoietic Stem CellsHematopoietic Stem Cell TransplantationInterferonsMacrophagesMiceMice, Inbred C57BLMyeloid CellsInterferons

Identifiers

PMID27590115
PMCPMC5054720
OpenAlexW2517782886

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.